Multicentric reticulohistiocytosis (MRH) is a rare disease with poorly defined therapeutic strategies. Here, we report the case of a patient with eosinophilic gastroenteritis who developed MRH after 5 years. The patient presented with disabling and rapidly progressive polyarthralgia, eosinophilic gastroenteritis, and resistance to first-line therapies. However, there was a marked improvement in the arthritis symptoms following treatment with tofacitinib. This presentation provides a useful perspective for the therapeutic management of complex scenarios involving MRH.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/1756-185X.14625 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!